BICYCLE T CELL MODULATOR
LIVE

Serial Number

79240290

Owner

Bicycletx Limited

Attorney

Christina M. Licursi

Filing Date

Mar 9, 2018

Add to watchlist:

No watchlists yet
View on USPTO

BICYCLE T CELL MODULATOR Trademark

Serial Number: 79240290 • Registration: 5809259

BICYCLE T CELL MODULATOR is a trademark filed by Bicycletx Limited on March 9, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Bicycletx Limited (33 trademarks)

Blocks A & B Portway Building,

Entity Type: 99

Bicycle Therapeutics Limited (8 trademarks)

Meditrina Building,

Entity Type: 99

Trademark Details

Filing Date

March 9, 2018

Registration Date

July 23, 2019

Published for Opposition

May 7, 2019

Cancellation Date

February 6, 2026

Goods & Services

Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; information, consultancy and advisory services relating to the aforesaid

Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents

Filing History

CANCELLED SECTION 71
Feb 6, 2026 C71T
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 26, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 26, 2025 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 23, 2024 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Dec 1, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Sep 24, 2022 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Sep 17, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 1, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 13, 2019 FICS
FINAL DISPOSITION PROCESSED
Nov 13, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2019 PUBO
NOTIFICATION PROCESSED BY IB
May 3, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 17, 2019 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2019 TEME
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 22, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 22, 2019 REAP
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2019 TROA
CHANGE OF OWNER RECEIVED FROM IB
Mar 21, 2019 CHLD
REFUSAL PROCESSED BY IB
Oct 13, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 25, 2018 RFCS
REFUSAL PROCESSED BY MPU
Sep 25, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 21, 2018 RFCR
NON-FINAL ACTION WRITTEN
Sep 20, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 18, 2018 MAFR
ASSIGNED TO EXAMINER
Sep 13, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 13, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 6, 2018 REPR